Advertisement

ALK anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project

Kerry J. Savage, Nancy Lee Harris, Julie M. Vose, Fred Ullrich, Elaine S. Jaffe, Joseph M. Connors, Lisa Rimsza, Stefano A. Pileri, Mukesh Chhanabhai, Randy D. Gascoyne, James O. Armitage and Dennis D. Weisenburger for the International Peripheral T-Cell Lymphoma Project

Article Information

Citation 
vol. 111 no. 12 5496-5504
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted January 26, 2008
  • Accepted March 18, 2008
  • Published online June 10, 2008.

Article Versions


Contributors 
  • Kerry J. Savage, 1Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC;
  • Nancy Lee Harris, 2Department of Pathology, Massachusetts General Hospital, Boston;
  • Julie M. Vose, Departments of 3Internal Medicine and
  • Fred Ullrich, 4Preventive and Societal Medicine, University of Nebraska Medical Center, Omaha;
  • Elaine S. Jaffe, 5Department of Hematopathology, National Cancer Institute, Bethesda, MD;
  • Joseph M. Connors, 1Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC;
  • Lisa Rimsza, 6Department of Pathology, University of Arizona, Tucson;
  • Stefano A. Pileri, 7 Department of Pathology, Bologna University School of Medicine, Bologna, Italy;
  • Mukesh Chhanabhai, 8Department of Pathology, British Columbia Cancer Agency, Vancouver, BC; and
  • Randy D. Gascoyne, 8Department of Pathology, British Columbia Cancer Agency, Vancouver, BC; and
  • James O. Armitage, Departments of 3Internal Medicine and
  • Dennis D. Weisenburger, 9Department of Pathology, University of Nebraska Medical Center, Omaha

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output